Pyridostigmine Bromide

Product NDC: 58657-810
11-digit product format: 586570810
Labeler code: 58657
Product ID: 58657-810_41b66d64-08b1-bd0c-e063-6394a90a5b86
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: PYRIDOSTIGMINE BROMIDE
Dosage form: TABLET
Route: ORAL
Labeler: Method Pharmaceuticals, LLC
Application: ANDA211181
Marketing category: ANDA
Marketing start: 2019-06-01
Substance: PYRIDOSTIGMINE BROMIDE
Active strength: 30 mg/1
Pharmacologic classes: Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	58657-810	58657-810-10	D	Discontinued by firm		2026-08-11
excluded package	package	58657-810	58657-810-30	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	58657-810-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	58657-810-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	58657-810-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	58657-810-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	58657-810-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	58657-810-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	58657-810-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	58657-810-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	58657-810-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	58657-810-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	58657-810-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	58657-810-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	58657-810-10	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	58657-810-30	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	58657-810-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	58657-810-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	58657-810-10	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	58657-810-30	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	58657-810-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	58657-810-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	58657-810-10	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	58657-810-30	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	58657-810-10	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	58657-810-30	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A211181-001	PYRIDOSTIGMINE BROMIDE	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB		2018-07-20
A211181-002	PYRIDOSTIGMINE BROMIDE	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB		2019-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A211181-001	AB
A211181-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL	AB	2019-05-14	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL		2019-05-14	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL		2019-05-14	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL		2019-05-14	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL		2019-05-14	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL		2019-05-14	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A211181-001	PYRIDOSTIGMINE BROMIDE	60MG	TABLET / ORAL	AB	2018-07-20	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A211181-002	PYRIDOSTIGMINE BROMIDE	30MG	TABLET / ORAL		2019-05-14	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 69 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211181-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A211181-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211181-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211181-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211181-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A211181-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211181-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211181-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211181-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211181-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211181-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211181-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211181-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211181-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211181-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211181-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211181-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211181-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211181-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A211181-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211181-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211181-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211181-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211181-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211181-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211181-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211181-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A211181-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211181-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211181-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211181-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A211181-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A211181-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A211181-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A211181-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A211181-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A211181-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A211181-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A211181-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A211181-001	AB	1	`b00525d2431f…`

Additional Listing Data#

Finished product: Yes
Brand name base: Pyridostigmine Bromide
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PYRIDOSTIGMINE BROMIDE	30 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
KVI301NA53	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
903841	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e756717f-941b-42f2-ba3b-03798c005ae7	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cd6f4a37-8abf-2ed8-817f-5becdfa53ca5	Product name	9	20230112
dd640b44-88ec-4cbe-02c0-23127b95f5d3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
58657-810-10	Pyridostigmine Bromide	10 in 1 BLISTER PACK	TABLET	10	9
58657-810-10	Pyridostigmine Bromide	21 in 1 CARTON	TABLET	21	9
58657-810-21	Pyridostigmine Bromide	21 in 1 BOTTLE	TABLET	21	9
58657-810-30	Pyridostigmine Bromide	30 in 1 CARTON	TABLET	30	9
58657-810-30	Pyridostigmine Bromide	3 in 1 CARTON	TABLET	3	9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58657-810-10	EA - Each	58657-810	3f729235-2f08-4596-b6d8-e620879905e4	1	2020-06-05
58657-810-21	EA - Each	58657-810	3afd0c04-5d77-473e-93c9-8cfeb0d139bf	1	2019-07-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58657-810	PYRIDOSTIGMINE BROMIDE TABLET [METHOD PHARMACEUTICALS, LLC]	8	Current NDC, Legacy NDC, 5 package rows	20241126_e756717f-941b-42f2-ba3b-03798c005ae7.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pyridostigmine Bromide	PYRIDOSTIGMINE BROMIDE	Method Pharmaceuticals, LLC	1aa7a886-c726-cc91-e063-6294a90a1af1	2026-02-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211181 application number: ANDA211181
Pyridostigmine Bromide	PYRIDOSTIGMINE BROMIDE	Method Pharmaceuticals, LLC	e756717f-941b-42f2-ba3b-03798c005ae7	2025-10-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211181 application number: ANDA211181 ndc (product): 58657-810

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
KVI301NA53	PYRIDOSTIGMINE BROMIDE	101-26-8	PYRIDOSTIGMINE BROMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
903841	pyRIDostigmine bromide 30 MG Oral Tablet	PSN	e756717f-941b-42f2-ba3b-03798c005ae7	9
903841	pyridostigmine bromide 30 MG Oral Tablet	SCD	e756717f-941b-42f2-ba3b-03798c005ae7	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
58657-810-10	58657081010	21 BLISTER PACK in 1 CARTON (58657-810-10) > 10 TABLET in 1 BLISTER PACK	21 blister pack	2019-06-01	0000-00-00	No	No	Current
58657-810-21	58657081021	21 TABLET in 1 BOTTLE (58657-810-21)	21 tablet	2019-06-01	0000-00-00	No	No	Current
58657-810-30	58657081030	30 CARTON in 1 CARTON (58657-810-30) > 3 BLISTER PACK in 1 CARTON > 10 TABLET in 1 BLISTER PACK	30 carton	2019-06-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Pyridostigmine Bromide Tablets	Method Pharmaceuticals, LLC	2025-10-21	HUMAN PRESCRIPTION DRUG LABEL	9